Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astera Labs (ALAB) Cash & Equivalents (2023 - 2025)

Historic Cash & Equivalents for Astera Labs (ALAB) over the last 3 years, with Q3 2025 value amounting to $140.4 million.

  • Astera Labs' Cash & Equivalents rose 1133.07% to $140.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $140.4 million, marking a year-over-year increase of 1133.07%. This contributed to the annual value of $79.6 million for FY2024, which is 7639.58% up from last year.
  • Per Astera Labs' latest filing, its Cash & Equivalents stood at $140.4 million for Q3 2025, which was up 1133.07% from $162.3 million recorded in Q2 2025.
  • Over the past 5 years, Astera Labs' Cash & Equivalents peaked at $696.1 million during Q1 2024, and registered a low of $45.1 million during Q4 2023.
  • In the last 3 years, Astera Labs' Cash & Equivalents had a median value of $133.3 million in 2024 and averaged $219.6 million.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 7639.58% in 2024, then plummeted by 8758.31% in 2025.
  • Quarter analysis of 3 years shows Astera Labs' Cash & Equivalents stood at $45.1 million in 2023, then surged by 76.4% to $79.6 million in 2024, then soared by 76.5% to $140.4 million in 2025.
  • Its Cash & Equivalents was $140.4 million in Q3 2025, compared to $162.3 million in Q2 2025 and $86.4 million in Q1 2025.